Company intelligence / Profile preview

Suntrition

Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Suntrition was a Canadian nutraceutical contract manufacturing organization (CMO) founded in 2001 by Grant Bourdeau. It specialized in creating unique, evidence-based natural supplements, primarily in tablet, capsule, and powder formulations. The company grew significantly, operating a state-of-the-art pharmaceutical GMP facility and being recognized as one of Canada's fastest-growing companies for four consecutive years. In 2015, Suntrition merged with Biomedcore to form Acenzia, ceasing independent operations.

Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Suntrition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suntrition.

Explore the full profile